This innovative process has demonstrated an ability to increase production yields by approximately 20% from the same starting plasma volume. “This approval represents a pivotal milestone for ...

(RTTNews) - ADMA Biologics, Inc. (ADMA) Monday said that the United States Food and Drug Administration (FDA) has approved the company's innovative production yield enhancement process. The ...

margin expansion and production output capacity as a result of FDA approval of the yield enhancement process, and timing related thereto, and our R&D platform. Actual events or results may differ ...

"As the first U.S. producer of plasma-derived products to achieve regulatory approval for its innovative yield enhancement production process, ADMA continues to demonstrate its leadership in ...

Dr. Naga Chandrasekaran, Intel's Chief Global Operations Officer and General Manager of Foundry Production and Supply Chain, also showcased a sample 18A process wafer produced at the Oregon factory on ...

This innovative process has demonstrated an ability to increase production yields by approximately 20% from the same starting plasma volume. “This approval represents a pivotal milestone for ADMA, ...